PDQ (Physician Data Query) es una marca registrada. Se autoriza el libre uso del texto de los documentos del PDQ. Sin embargo, no se podrá identificar como un sumario de información sobre cáncer del PDQ del NCI, salvo que se reproduzca en su totalidad y se actualice con regularidad. Por otra parte, se permitirá que un autor escriba una oración como “En el sumario del PDQ del NCI de información sobre la prevención del cáncer de mama se describen, en breve, los siguientes riesgos: [incluir fragmento del sumario]”.
But he wasn’t finished. In February of 1980, Dr. Mechoulam teamed up with South American researchers to publish a study regarding cannabis and epilepsy. This study is seen as one of the earliest double-blind studies of CBD on clinical subjects. The study Dr. Mechoulam and his team conducted included 16 people, many of whom were children, who all suffered from severe epilepsy. The results were startling: Every subject who received CBD experienced improvement in their condition with little to no side effects. This anticonvulsant study has since proven to be an integral milestone in the world of clinical marijuana research, but largely went unnoticed at the time.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.


Se han llevado a cabo varios ensayos clínicos controlados y metanálisis en los que se sustenta un efecto beneficioso de los canabinoides (dronabinol y nabilona) en las náuseas y los vómitos (NyV) inducidos por la quimioterapia en comparación con un placebo. La Administración de Alimentos y Medicamentos de los Estados Unidos aprobó tanto el dronabinol como la nabilona para la prevención o el tratamiento de las NyV inducidos por la quimioterapia en pacientes de cáncer, pero no para otro tipo de tratamiento sintomático.

Cultivado en por lo menos 30 países, apodos para el cáñamo seguido se refieren a su origen o a su uso, como es el cáñamo Manila (abacá, Musa Textilis), cáñamo sisal (Agave sisalana), cáñamo Indú (Apocynumcannabinum) y cáñamo de Nueva Zelandia (Phormiumtenax). En el mundo entero, tan sólo la producción de semillas de cáñamo ha aumentado de alrededor de 33,000 toneladas métricas a finales de los ’90s a más de 100,000 toneladas métricas anualmente entre 2005 y 2011.

CBD oil may be of some benefit to those with addiction, suggests a review published in the journal Substance Abuse in 2015. In their analysis of 14 previously published studies, scientists determined that CBD may have therapeutic effects in people with opioid, cocaine, and/or psychostimulant addiction. They also found that CBD may be beneficial in the treatment of cannabis and tobacco addiction. There is some evidence that CBD may block or reduce the effects of THC on the mind.
In 2015, The Hebrew University of Israel published a study that documented the potency of single-molecule CBD extract versus the potency of whole-plant CBD-rich extract. It found that extract taken from whole plant CBD-rich cannabis is therapeutically superior to single-molecule extract. The scientists behind this study noticed that science had been utilizing pure, single-molecule CBD, which resulted in a bell-shaped dose-response curve. This means that CBD’s efficacy plummets at very high and very low doses.

Aceite De CBD De Espectro Completo

×